NEW YORK (GenomeWeb) – PGXL Laboratories has received licensure from California to provide its testing services in the state.

As a result, the Louisville, Ky.-based company can offer its testing services in all 50 states in the US, it said. According to PGXL's website, it provides pharmacogenetic tests for CYP2C19, CYP2D6, Factor V Leiden, Factor II, and others. It also offers molecular oncology testing for the detection of EGFR, HER2/neu (fluorescent in situ hybridization), JAK2, ALK (FISH), and other genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.